Novo Nordisk Stock: Buy, Sell, or Hold as FDA Approves Wegovy Pill

The FDA has approved a new weight loss pill called Wegovy, developed by Novo Nordisk. The pill is designed to help people lose weight by reducing appetite and increasing feelings of fullness. The approval of Wegovy is expected to boost Novo Nordisk's sales and stock price. Investors should consider buying or holding the stock based on their individual investment strategies and risk tolerance.